Opioid and neuroHIV comorbidity–current and future perspectives
With the current national opioid crisis, it is critical to examine the mechanisms underlying
pathophysiologic interactions between human immunodeficiency virus (HIV) and opioids in …
pathophysiologic interactions between human immunodeficiency virus (HIV) and opioids in …
The Combined Effects of Cannabis, Methamphetamine, and HIV on Neurocognition
JM Rogers, JE Iudicello, MCG Marcondes, EE Morgan… - Viruses, 2023 - mdpi.com
Objective: Methamphetamine and cannabis are two widely used substances among people
living with HIV (PLWH). Whereas methamphetamine use has been found to worsen HIV …
living with HIV (PLWH). Whereas methamphetamine use has been found to worsen HIV …
[HTML][HTML] Astrocytes: Role in pathogenesis and effect of commonly misused drugs in the HIV infected brain
J Pla-Tenorio, AM Roig, PA García-Cesaní… - Current Research in …, 2023 - Elsevier
The roles of astrocytes as reservoirs and producers of a subset of viral proteins in the HIV
infected brain have been studied extensively as a key to understanding HIV-associated …
infected brain have been studied extensively as a key to understanding HIV-associated …
Cocaine regulates antiretroviral therapy CNS access through pregnane-x receptor-mediated drug transporter and metabolizing enzyme modulation at the blood brain …
R Colón Ortiz, S Knerler, LB Fridman… - Fluids and Barriers of …, 2024 - Springer
Background Appropriate interactions between antiretroviral therapies (ART) and drug
transporters and metabolizing enzymes at the blood brain barrier (BBB) are critical to ensure …
transporters and metabolizing enzymes at the blood brain barrier (BBB) are critical to ensure …
Cocaine use may moderate the associations of HIV and female sex with neurocognitive impairment in a predominantly african American population disproportionately …
H Lai, DD Celentano, G Treisman, J Khalsa… - AIDS patient care and …, 2023 - liebertpub.com
HIV-associated neurocognitive disorders (HAND) remain a major challenge for people with
HIV in the antiretroviral therapy era. Cocaine use may trigger/exacerbate HAND among …
HIV in the antiretroviral therapy era. Cocaine use may trigger/exacerbate HAND among …
Cognitive phenotypes of HIV defined using a novel data-driven approach
RH Paul, K Cho, A Belden, AW Carrico, E Martin… - Journal of Neuroimmune …, 2022 - Springer
The current study applied data-driven methods to identify and explain novel cognitive
phenotypes of HIV. Methods: 388 people with HIV (PWH) with an average age of 46 (15.8) …
phenotypes of HIV. Methods: 388 people with HIV (PWH) with an average age of 46 (15.8) …
Effects of substance use on monetary delay discounting among people who use stimulants with and without HIV: An ecological momentary assessment study.
Y Xu, SL Towe, ST Causey, PA Dennis… - Experimental and …, 2022 - psycnet.apa.org
Exploration of the real-time relationship between substance use and delay discounting may
reveal potential mechanisms driving high-risk behaviors. We conducted an ecological …
reveal potential mechanisms driving high-risk behaviors. We conducted an ecological …
Neurocognitive course at 2-year follow-up in a Swiss cohort of people with well-treated HIV
J Damas, B Ledergerber, I Nadin, PE Tarr, M Stoeckle… - Aids, 2021 - journals.lww.com
Objective: The aim of this study was to examine neurocognitive course over time among
people with well treated HIV. Design: The Neurocognitive Assessment in the Metabolic and …
people with well treated HIV. Design: The Neurocognitive Assessment in the Metabolic and …
[HTML][HTML] Cocaine Regulates Antiretroviral Therapy CNS Access Through Pregnane-X Receptor-Mediated Drug Transporter and Metabolizing Enzyme Modulation at …
LB Fridman, S Knerler, AS Price, RC Ortiz, A Mercado… - bioRxiv, 2023 - ncbi.nlm.nih.gov
Background Appropriate interactions between antiretroviral therapies (ART) and drug
transporters and metabolizing enzymes at the blood brain barrier (BBB) are critical to ensure …
transporters and metabolizing enzymes at the blood brain barrier (BBB) are critical to ensure …
Neurocognitive course at two-year follow-up in the neurocognitive assessment in the metabolic and aging cohort (NAMACO) study.
J Damas, B Ledergerber, I Nadin, PE Tarr, M Stoeckle… - Aids, 2021 - boris.unibe.ch
OBJECTIVE To examine neurocognitive course over time among people with well-treated
HIV. DESIGN The Neurocognitive Assessment in the Metabolic and Aging Cohort …
HIV. DESIGN The Neurocognitive Assessment in the Metabolic and Aging Cohort …